Cohen, Jonathon B <br/><br/>
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study.  [electronic resource] 

 -  Cancer  03 2020 
 - 1235-1242 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0142 
<br/><br/><label>Standard No.: </label>10.1002/cncr.32640  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bendamustine Hydrochloride--administration & dosage<br/>Bleomycin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Drug Administration Schedule<br/>Drug Resistance, Neoplasm<br/>Female<br/>Hodgkin Disease--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Progression-Free Survival<br/>Recurrence<br/>Salvage Therapy--methods<br/>Young Adult<br/>Gemcitabine